Psilocybin research is no longer just for hard-to-treat cases — a new trial targeted recurrent depression in people who had not failed standard treatment, and the results are promising

Most of the psilocybin research that has made headlines over the past decade has carried an implicit qualifier: this is for people for whom nothing else has worked. The participants enrolled in those…